What is Stran & Company's earnings per share (EPS)?

Stran & Company (SWAGW) reported diluted earnings per share of $-0.22 for fiscal year 2024. This represents a -1000.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Stran & Company Financials

SWAGW

Source SEC Filings (10-K/10-Q) Updated Sep 30, 2025 Currency USD FYE December

This page shows Stran & Company (SWAGW) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial Profile 35/100

Based on FY2024 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability

Stran & Company has an operating margin of -5.9%, meaning the company retains $-6 of operating profit per $100 of revenue. This below-average margin results in a low score of 9/100, suggesting thin profitability after operating expenses. This is down from -1.7% the prior year.

Growth

Stran & Company's revenue grew 8.8% year-over-year to $82.7M, a solid pace of expansion. This earns a growth score of 48/100.

Leverage

Stran & Company carries a low D/E ratio of 0.74, meaning only $0.74 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 87/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

Stran & Company's current ratio of 2.05 indicates adequate short-term liquidity, earning a score of 37/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow

Stran & Company has a free cash flow margin of 2.6%, earning a moderate score of 32/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns

Stran & Company generates a -13.1% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 0/100. This is down from -1.1% the prior year.

Piotroski F-Score Weak

2/9

Stran & Company passes 2 of 9 financial strength tests. 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.

Earnings Quality Mixed

-0.67x

For every $1 of reported earnings, Stran & Company generates $-0.67 in operating cash flow ($2.8M OCF vs -$4.1M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$82.7M

YoY+8.8%

Stran & Company generated $82.7M in revenue in fiscal year 2024. This represents an increase of 8.8% from the prior year.

EBITDA

-$4.1M

YoY-720.6%

Stran & Company's EBITDA was -$4.1M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 720.6% from the prior year.

Net Income

-$4.1M

YoY-975.3%

Stran & Company reported -$4.1M in net income in fiscal year 2024. This represents a decrease of 975.3% from the prior year.

EPS (Diluted)

$-0.22

YoY-1000.0%

Stran & Company earned $-0.22 per diluted share (EPS) in fiscal year 2024. This represents a decrease of 1000.0% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$2.2M

YoY+160.8%

Stran & Company generated $2.2M in free cash flow in fiscal year 2024, representing cash available after capex. This represents an increase of 160.8% from the prior year.

Cash & Debt

$9.4M

YoY+16.1%

Stran & Company held $9.4M in cash against $0 in long-term debt as of fiscal year 2024.

Dividends Per Share

N/A

Shares Outstanding

19M

YoY+0.4%

Stran & Company had 19M shares outstanding in fiscal year 2024. This represents an increase of 0.4% from the prior year.

Margins & Returns

Gross Margin

31.2%

YoY-1.5pp

Stran & Company's gross margin was 31.2% in fiscal year 2024, indicating the percentage of revenue retained after direct costs. This is down 1.5 percentage points from the prior year.

Operating Margin

-5.9%

YoY-4.3pp

Stran & Company's operating margin was -5.9% in fiscal year 2024, reflecting core business profitability. This is down 4.3 percentage points from the prior year.

Net Margin

-5.0%

YoY-4.5pp

Stran & Company's net profit margin was -5.0% in fiscal year 2024, showing the share of revenue converted to profit. This is down 4.5 percentage points from the prior year.

Return on Equity

-13.1%

YoY-12.0pp

Stran & Company's ROE was -13.1% in fiscal year 2024, measuring profit generated per dollar of shareholder equity. This is down 12.0 percentage points from the prior year.

Capital Allocation

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

$601K

YoY-39.8%

Stran & Company invested $601K in capex in fiscal year 2024, funding long-term assets and infrastructure. This represents a decrease of 39.8% from the prior year.

SWAGW Income Statement

Metric	FY24	FY23	FY22	FY21	FY20
Revenue	$82.7M+8.8%	$76.0M+31.3%	$57.9M+45.8%	$39.7M+5.2%	$37.8M
Cost of Revenue	$56.8M+11.1%	$51.1M+20.4%	$42.5M+52.5%	$27.9M+6.1%	$26.3M
Gross Profit	$25.8M+3.9%	$24.9M+61.5%	$15.4M+30.0%	$11.8M+3.1%	$11.5M
R&D Expenses	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$30.7M+21.3%	$25.3M+42.3%	$17.8M+44.9%	$12.3M+22.8%	$10.0M
Operating Income	-$4.9M-286.0%	-$1.3M+64.6%	-$3.6M-718.9%	-$438K-129.4%	$1.5M
Interest Expense	N/A	$570K+500.0%	$95K-30.5%	$137K+176.3%	$49K
Income Tax	$5K-87.8%	$41K-81.5%	$222K+306.5%	-$108K-125.5%	$422K
Net Income	-$4.1M-975.3%	-$385K+89.0%	-$3.5M-1587.8%	$235K-77.1%	$1.0M
EPS (Diluted)	$-0.22-1000.0%	$-0.02+88.9%	$-0.18-1900.0%	$0.01-90.0%	$0.10

Metric	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23
Revenue	$26.0M-20.2%	$32.6M+13.5%	$28.7M+6.3%	$27.0M+34.0%	$20.1M+20.7%	$16.7M-11.3%	$18.8M-17.9%	$22.9M
Cost of Revenue	$18.9M-16.7%	$22.7M+12.3%	$20.2M+11.0%	$18.2M+28.3%	$14.2M+26.4%	$11.2M-15.0%	$13.2M-12.8%	$15.1M
Gross Profit	$7.1M-28.3%	$9.9M+16.4%	$8.5M-3.4%	$8.8M+47.5%	$6.0M+8.9%	$5.5M-2.6%	$5.6M-28.0%	$7.8M
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$8.9M-6.5%	$9.5M+5.1%	$9.0M-7.2%	$9.7M+19.4%	$8.1M+23.7%	$6.6M+4.7%	$6.3M-14.5%	$7.3M
Operating Income	-$1.8M-551.1%	$395K+173.8%	-$535K+42.9%	-$937K+57.1%	-$2.2M-97.1%	-$1.1M-66.6%	-$665K-86.8%	-$356K
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$103K
Income Tax	-$72K-163.2%	$114K+400.0%	-$38K	N/A	-$1K-133.3%	$3K	N/A	$26K
Net Income	-$1.2M-292.8%	$643K+263.6%	-$393K+32.9%	-$586K+71.2%	-$2.0M-98.8%	-$1.0M-108.8%	-$491K-102.9%	-$242K
EPS (Diluted)	$-0.07-333.3%	$0.03+250.0%	$-0.02	N/A	$-0.11-83.3%	$-0.06-100.0%	$-0.03	N/A

SWAGW Balance Sheet

Metric	FY24	FY23	FY22	FY21	FY20
Total Assets	$55.1M+12.5%	$49.0M-2.4%	$50.2M-1.9%	$51.2M+284.9%	$13.3M
Current Assets	$45.5M+5.7%	$43.0M-6.6%	$46.1M-3.1%	$47.6M+412.9%	$9.3M
Cash & Equivalents	$9.4M+16.1%	$8.1M-47.2%	$15.3M-52.7%	$32.2M+4879.1%	$647K
Inventory	$5.4M+12.7%	$4.8M-19.3%	$5.9M+13.3%	$5.2M+109.3%	$2.5M
Accounts Receivable	$18.1M+11.5%	$16.2M+18.0%	$13.8M+53.1%	$9.0M+58.2%	$5.7M
Goodwill	$2.3M	N/A	$90K-73.1%	$335K	N/A
Total Liabilities	$23.5M+75.6%	$13.4M-7.8%	$14.5M+42.7%	$10.2M-12.9%	$11.7M
Current Liabilities	$22.2M+98.4%	$11.2M-14.9%	$13.1M+67.9%	$7.8M-2.1%	$8.0M
Long-Term Debt	N/A	N/A	$460K-41.4%	$785K	N/A
Total Equity	$31.6M-11.2%	$35.6M-0.2%	$35.7M-13.0%	$41.0M+2420.8%	$1.6M
Retained Earnings	-$6.7M-159.1%	-$2.6M-17.4%	-$2.2M-219.1%	$1.9M+14.5%	$1.6M

Metric	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23
Total Assets	$50.3M-17.9%	$61.2M+17.4%	$52.2M-5.4%	$55.1M+13.0%	$48.8M+4.8%	$46.6M-2.8%	$47.9M-2.2%	$49.0M
Current Assets	$39.3M-21.5%	$50.1M+18.7%	$42.2M-7.2%	$45.5M+17.7%	$38.6M-5.4%	$40.9M-2.8%	$42.0M-2.3%	$43.0M
Cash & Equivalents	$6.7M-48.8%	$13.1M+208.5%	$4.2M-54.7%	$9.4M-6.8%	$10.0M-15.5%	$11.9M+25.2%	$9.5M+17.7%	$8.1M
Inventory	$7.7M+14.9%	$6.7M-12.0%	$7.7M+42.1%	$5.4M+13.0%	$4.8M+20.0%	$4.0M-6.1%	$4.2M-11.5%	$4.8M
Accounts Receivable	$16.6M-24.6%	$22.1M+20.6%	$18.3M+1.1%	$18.1M+31.6%	$13.7M+14.4%	$12.0M-15.4%	$14.2M-12.4%	$16.2M
Goodwill	$2.3M0.0%	$2.3M0.0%	$2.3M0.0%	$2.3M-8.7%	$2.5M	N/A	N/A	N/A
Total Liabilities	$20.1M-31.7%	$29.4M+40.7%	$20.9M-11.1%	$23.5M+42.4%	$16.5M+34.1%	$12.3M-3.1%	$12.7M-5.1%	$13.4M
Current Liabilities	$17.3M-34.9%	$26.6M+38.4%	$19.2M-13.3%	$22.2M+48.8%	$14.9M+40.0%	$10.7M+0.2%	$10.6M-4.9%	$11.2M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$30.2M-5.1%	$31.8M+1.8%	$31.3M-1.2%	$31.6M-2.0%	$32.3M-5.8%	$34.3M-2.7%	$35.2M-1.1%	$35.6M
Retained Earnings	-$7.7M-19.1%	-$6.5M+9.0%	-$7.1M-5.8%	-$6.7M-9.5%	-$6.2M-49.5%	-$4.1M-33.3%	-$3.1M-18.7%	-$2.6M

SWAGW Cash Flow Statement

Metric	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$2.8M+208.2%	-$2.5M-27.5%	-$2.0M+62.2%	-$5.3M-165.9%	-$2.0M
Capital Expenditures	$601K-39.8%	$999K+59.6%	$626K+60.9%	$389K+120.4%	$176K
Free Cash Flow	$2.2M+160.8%	-$3.5M-35.1%	-$2.6M+53.8%	-$5.7M-162.2%	-$2.2M
Investing Cash Flow	-$533K+85.7%	-$3.7M+69.6%	-$12.3M-3057.2%	-$389K	N/A
Financing Cash Flow	-$928K-2.1%	-$909K+66.2%	-$2.7M-107.2%	$37.3M+9812.1%	$376K
Dividends Paid	N/A	$100K	N/A	N/A	N/A
Share Buybacks	N/A	$50K-98.5%	$3.3M	N/A	N/A

Metric	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23
Operating Cash Flow	-$5.4M-183.5%	$6.4M+209.1%	-$5.9M-541.9%	$1.3M+148.6%	-$2.7M-230.0%	$2.1M+2.4%	$2.1M+316.3%	-$952K
Capital Expenditures	$498K+538.5%	$78K-37.1%	$124K+33.3%	$93K-35.4%	$144K-18.2%	$176K-6.4%	$188K-7.8%	$204K
Free Cash Flow	-$5.9M-192.4%	$6.3M+205.5%	-$6.0M-585.1%	$1.2M+143.0%	-$2.9M-249.3%	$1.9M+3.3%	$1.9M+261.9%	-$1.2M
Investing Cash Flow	-$572K-119.8%	$2.9M+258.0%	$809K+139.5%	-$2.0M-284.9%	$1.1M+13.1%	$980K+271.3%	-$572K-88.2%	-$304K
Financing Cash Flow	-$433K+11.1%	-$487K-1117.5%	-$40K-205.3%	$38K+118.4%	-$206K+70.6%	-$700K-1066.7%	-$60K-27.7%	-$47K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$408K	N/A	N/A	N/A	N/A	N/A	N/A	$26K

SWAGW Financial Ratios

Metric	FY24	FY23	FY22	FY21	FY20
Gross Margin	31.2%-1.5pp	32.7%+6.1pp	26.6%-3.2pp	29.8%-0.6pp	30.4%
Operating Margin	-5.9%-4.3pp	-1.7%+4.5pp	-6.2%-5.1pp	-1.1%-5.1pp	4.0%
Net Margin	-5.0%-4.5pp	-0.5%+5.5pp	-6.0%-6.6pp	0.6%-2.1pp	2.7%
Return on Equity	-13.1%-12.0pp	-1.1%+8.7pp	-9.8%-10.4pp	0.6%-62.6pp	63.2%
Return on Assets	-7.5%-6.7pp	-0.8%+6.2pp	-7.0%-7.4pp	0.5%-7.3pp	7.7%
Current Ratio	2.05-1.8	3.85+0.3	3.51-2.6	6.07+4.9	1.16
Debt-to-Equity	0.74+0.4	0.38+0.4	0.010.0	0.02-7.2	7.17
FCF Margin	2.6%+7.3pp	-4.7%-0.1pp	-4.5%+9.8pp	-14.3%-8.6pp	-5.7%

Metric	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23
Gross Margin	27.2%-3.1pp	30.3%+0.7pp	29.6%-3.0pp	32.5%+3.0pp	29.5%-3.2pp	32.8%+2.9pp	29.8%-4.2pp	34.0%
Operating Margin	-6.9%-8.1pp	1.2%+3.1pp	-1.9%+1.6pp	-3.5%+7.4pp	-10.8%-4.2pp	-6.6%-3.1pp	-3.5%-2.0pp	-1.6%
Net Margin	-4.8%-6.7pp	2.0%+3.3pp	-1.4%+0.8pp	-2.2%+8.0pp	-10.1%-4.0pp	-6.1%-3.5pp	-2.6%-1.6pp	-1.1%
Return on Equity	-4.1%-6.1pp	2.0%+3.3pp	-1.3%+0.6pp	-1.8%+4.5pp	-6.3%-3.3pp	-3.0%-1.6pp	-1.4%-0.7pp	-0.7%
Return on Assets	-2.5%-3.5pp	1.1%+1.8pp	-0.8%+0.3pp	-1.1%+3.1pp	-4.2%-2.0pp	-2.2%-1.2pp	-1.0%-0.5pp	-0.5%
Current Ratio	2.27+0.4	1.88-0.3	2.20+0.1	2.05-0.5	2.59-1.2	3.83-0.1	3.95+0.1	3.85
Debt-to-Equity	0.66-0.3	0.92+0.3	0.67-0.1	0.74+0.2	0.51+0.2	0.360.0	0.36-0.0	0.38
FCF Margin	-22.6%-42.1pp	19.5%+40.4pp	-21.0%-25.6pp	4.6%+18.9pp	-14.3%-25.9pp	11.6%+1.6pp	9.9%+15.0pp	-5.0%

Similar Companies

Cheer Holding GSMGW

Stran & Company Inc SWAG

$31.0M

Hainan Manaslu Acquisition Corp ABLVW

Fluent, Inc. FLNT

$99.3M

CTRL Group Ltd MCTR

$14.9M

Frequently Asked Questions

What is Stran & Company's annual revenue?

Stran & Company (SWAGW) reported $82.7M in total revenue for fiscal year 2024. This represents a 8.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Stran & Company's revenue growing?

Stran & Company (SWAGW) revenue grew by 8.8% year-over-year, from $76.0M to $82.7M in fiscal year 2024.

Is Stran & Company profitable?

No, Stran & Company (SWAGW) reported a net income of -$4.1M in fiscal year 2024, with a net profit margin of -5.0%.

What is Stran & Company's EBITDA?

Stran & Company (SWAGW) had EBITDA of -$4.1M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.

What is Stran & Company's gross margin?

Stran & Company (SWAGW) had a gross margin of 31.2% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.

What is Stran & Company's operating margin?

Stran & Company (SWAGW) had an operating margin of -5.9% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.

What is Stran & Company's net profit margin?

Stran & Company (SWAGW) had a net profit margin of -5.0% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.

What is Stran & Company's return on equity (ROE)?

Stran & Company (SWAGW) has a return on equity of -13.1% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.

What is Stran & Company's free cash flow?

Stran & Company (SWAGW) generated $2.2M in free cash flow during fiscal year 2024. This represents a 160.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Stran & Company's operating cash flow?

Stran & Company (SWAGW) generated $2.8M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.

What are Stran & Company's total assets?

Stran & Company (SWAGW) had $55.1M in total assets as of fiscal year 2024, including both current and long-term assets.

What are Stran & Company's capital expenditures?

Stran & Company (SWAGW) invested $601K in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.

How many shares does Stran & Company have outstanding?

Stran & Company (SWAGW) had 19M shares outstanding as of fiscal year 2024.

What is Stran & Company's current ratio?

Stran & Company (SWAGW) had a current ratio of 2.05 as of fiscal year 2024, which is generally considered healthy.

What is Stran & Company's debt-to-equity ratio?

Stran & Company (SWAGW) had a debt-to-equity ratio of 0.74 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Stran & Company's return on assets (ROA)?

Stran & Company (SWAGW) had a return on assets of -7.5% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.

What is Stran & Company's Piotroski F-Score?

Stran & Company (SWAGW) has a Piotroski F-Score of 2 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Stran & Company's earnings high quality?

Stran & Company (SWAGW) has an earnings quality ratio of -0.67x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Stran & Company?

Stran & Company (SWAGW) scores 35 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.